(Q38021509)

27 August 2017

title

microRNA regulation of cell viability and drug sensitivity in lung cancer (English)

1 reference

27 August 2017

1 reference

1 reference

Alexander Pertsemlidis

object named as

Alexander Pertsemlidis

series ordinal

2

1 reference

ORCID Public Data File 2021

Liqin Du

series ordinal

1

object named as

Liqin Du

1 reference

27 August 2017

language of work or name

English

0 references

publication date

26 June 2012

1 reference

Expert Opinion on Biological Therapy

27 August 2017

published in

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

1221-1239

1 reference

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

An E2F/miR-20a autoregulatory feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Modulation of mismatch repair and genomic stability by miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The immunoglobulin-like cell adhesion molecule hepaCAM is cleaved in the human breast carcinoma MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Suppression of non-small cell lung tumor development by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

α4 is highly expressed in carcinogen-transformed human cells and primary human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-449 in cell fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNAs modulate the chemosensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Retracted: An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA miR-548d is a superior regulator in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

microRNA-101 is a potent inhibitor of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

STAT3 mediates resistance to MEK inhibitor through microRNA miR-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Crizotinib: a drug that crystallizes a unique molecular subset of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

TRAIL: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA regulation of core apoptosis pathways in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA expression and clinical outcome of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Polymorphism in the 3'-untranslated region of the thymidylate synthase gene and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Improved targeting of miRNA with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

The utility of LNA in microRNA-based cancer diagnostics and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Lipid-based nanoparticles for nucleic acid delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Polymeric core-shell nanoparticles for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

Gene Expression Analysis in Blood Cells in Response to Unmodified and 2′-Modified siRNAs Reveals TLR-dependent and Independent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.697149

10.1517/14712598.2012.697149

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference